Steward Financial Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Steward Financial Group’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9	Closed	–	–	119
2022 Q2	$0	Buy	+9	New	+$33	﹤0.01%	958

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Financial Group's AMRX Position: Q3 2022 in Review

Steward Financial Group sold out of Amneal Pharmaceuticals (AMRX) in Q3 2022, closing a stake of 9 shares.

Steward Financial Group first reported a position in AMRX in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2022.

Steward Financial Group reported no remaining Amneal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Steward Financial Group sold 9 Amneal Pharmaceuticals shares in Q3 2022.
Steward Financial Group first reported a position in Amneal Pharmaceuticals in Q2 2022 and held it in 1 quarter.
Steward Financial Group's Amneal Pharmaceuticals position peaked at $0 in Q2 2022.
154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2022.

Based on Steward Financial Group's 13F filing for Q3 2022, filed 7 Nov 2022.